Platanus
Funding rounds backed by Platanus.
- Funding disclosed in full
- $50M
- Median round
- $50M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Poplar Therapeutics Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions | $50MSeries A | HealthtechUnited States |